Jacob F. Degner

ORCID: 0000-0003-4898-8575 · 2 papers in corpus · active 2018-2021

Study types

  • article 2

Condition tags

  • endometriosis 2
article 2021
Population Pharmacokinetics of Elagolix in Combination with Low-Dose Estradiol/Norethindrone Acetate in Women with Uterine Fibroids
Clinical pharmacokinetics ·doi:10.1007/s40262-021-01096-w

BACKGROUND AND OBJECTIVES: Elagolix is an orally active, gonadotropin-releasing hormone receptor antagonist approved for the management of endometriosis-associated pain and heavy menstrual bleeding associated with uterine fibroids. Elagolix…

article 2018
Population Pharmacokinetics of Elagolix in Healthy Women and Women with Endometriosis
Clinical pharmacokinetics ·doi:10.1007/s40262-018-0629-6